Frontlight ResearchEarly access
Trial site
Mass Gen Hosp Cancer Center
- 1running trial
- 1closed trial
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
Running trials
Active, not recruiting
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026